News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Micron's 5x forward P/E hides that trailing EPS and balance-sheet multiples already price strong execution.
  • Analyst proposes a defined-risk long trade with explicit entry, stop, and target levels.
  • The trade's primary catalyst is upcoming earnings guidance.
  • Execution misses are cited as the main risk that could erase near-term gains.
  • Micron's valuation limits upside for semiconductor peers without fresh demand proof.
  • Watch EPS revisions for confirmation of sustained demand before adding risk exposure.

Latest Articles

U.S. to Levy New Tariffs on Imported Drones and Components, White House Says

U.S. to Levy New Tariffs on Imported Drones and Components, White House Says

The White House announced a proclamation signed by President Donald Trump that will impose a series of tariffs on imported drones and related components, citing national security concerns and an overreliance on foreign suppliers. The measures establish tiered ad valorem duties based on the size and capabilities of unmanned aircraft systems and assi…

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

BridgeBio Pharma, a biopharmaceutical company focused on genetic conditions, announced a secondary offering of 5 million shares of its common stock by an existing shareholder, KKR Genetic Disorder L.P. The company itself is not selling any shares and will not receive proceeds from the offering. The offering is subject to market conditions and regul…

REalloys Reports Second Quarter 2026 Results

REalloys Reports Second Quarter 2026 Results

REalloys Inc. reported second quarter 2026 results highlighting a $0.8 million revenue and a $36.8 million net loss driven by stock-based compensation after its Nasdaq listing. The company has fully funded a major upgrade to its SRC Rare Earth Processing Facility targeting increased annual neodymium-praseodymium (NdPr), dysprosium, and terbium oxid…

Binah Capital Group Reports Results for Second Quarter of 2026

Binah Capital Group Reports Results for Second Quarter of 2026

Binah Capital Group, Inc. announced its financial results for Q2 2026, reporting a 13.4% year-over-year increase in Assets Under Management to $31.6 billion, a turnaround to net income of $0.3 million from a prior year net loss, and a substantial rise in EBITDA to $1.0 million. Total revenue increased by 12.1% to $46.5 million, demonstrating the co…

NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

NovaBridge Biosciences announced a webcast scheduled for August 20, 2026, to discuss the company's financial results for the first half ended June 30, 2026, along with recent corporate progress. The biotechnology company focuses on therapeutic programs in oncology and ophthalmology, aiming to advance innovation through a disciplined development and…

Stardust Power Reports Q2 2026 Financial Results and Business Update

Stardust Power Reports Q2 2026 Financial Results and Business Update

Stardust Power Inc. announced its Q2 2026 results, highlighting ongoing progress at its Muskogee lithium refinery, including site preparations and participation in a U.S. DOE-funded lithium extraction research initiative. Despite a net loss of $3.9 million and declining cash reserves reflecting continued investment, the company strengthened liquidi…

BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

BIO-key International, a Nasdaq-listed biometrics and IAM company, announced Q2 2026 revenues of $1.9 million, up 13% year-over-year, with a 51% reduction in net loss. Growth was driven by increased license fee revenue and global contracts in government, defense, and financial sectors, particularly in EMEA markets. The company also raised $2.5 mill…

Microsoft’s AI Inflection: How I’d Trade the Next Leg Higher

Microsoft’s AI Inflection: How I’d Trade the Next Leg Higher

Microsoft has moved beyond the skeptics' debate and into a clear growth phase driven by Azure, AI partnerships, and sticky enterprise revenue. Fundamentals - strong free cash flow, double-digit margins, and a fortress balance sheet - back a lean long trade. I lay out a concrete entry, stop, targets, catalysts, and the risks that would force me to f…

Skeena Gold & Silver Reports Q2 2026 Financial Results

Skeena Gold & Silver Reports Q2 2026 Financial Results

Skeena Resources Limited released its interim financial results for Q2 2026, highlighting progress on the Eskay Creek Gold-Silver Project in British Columbia. The fully permitted project is under construction, with initial production and cash flow expected in Q2 2027. Eskay Creek is projected to be a high-grade, low-cost open-pit precious metals mi…

Svatantra Microfin Seeks 30 Billion Rupee IPO in India

Svatantra Microfin Seeks 30 Billion Rupee IPO in India

Svatantra Microfin has filed draft papers for an initial public offering totaling 30 billion rupees ($314.33 million). The plan calls for up to 15 billion rupees from new share issuance and an equal amount from existing shareholders Advent International and Multiples. The filing comes as India’s primary market rebounds after a weak first half of th…

Maze Therapeutics Announces Appointments to Its Board of Directors

Maze Therapeutics Announces Appointments to Its Board of Directors

Maze Therapeutics announced the addition of Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its Board of Directors, bringing extensive clinical and biopharmaceutical experience. The appointments come as the company prepares for critical clinical data readouts and trial initiations for its kidney and metabolic disease drug ca…

Gemini Reports Second Quarter 2026 Results

Gemini Reports Second Quarter 2026 Results

Gemini Space Station, Inc. (NASDAQ: GEMI) reported strong Q2 2026 results with 37% year-over-year revenue growth to $45.5 million, driven by a 149% increase in services revenue, notably credit card and staking offerings, despite a 38% decline in exchange revenue due to softer crypto markets. The company improved operating loss sequentially by 18% t…

TWFG Expands Credit Facility to $125 Million, Enhancing Capacity for Continued Growth and Strategic Investments

TWFG Expands Credit Facility to $125 Million, Enhancing Capacity for Continued Growth and Strategic Investments

TWFG, Inc. has expanded its revolving credit facility to $125 million with an extended maturity to 2031, enhancing its liquidity and financial flexibility. The credit agreement with PNC Bank includes an uncommitted accordion feature potentially increasing borrowing capacity to $200 million. This financial move supports TWFG's growth strategy throug…

Caliber Reports Second Quarter 2026 Financial Results

Caliber Reports Second Quarter 2026 Financial Results

CaliberCos Inc. reported second quarter 2026 financial results showing Platform Adjusted EBITDA turning positive at $0.3 million, indicating progress towards profitability. Despite a decline in platform revenue to $3.7 million, the company reaffirmed full-year 2026 guidance and highlighted major milestones including the groundbreaking of its Steamb…